New York, New York–(Newsfile Corp. – May 18, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American:Read More
You might also be interested in reading SEC Orders First Trust-SkyBridge to Declare its Bitcoin ETF Application Abandoned.